The Board of Directors of Chemclin Diagnostics Co., Ltd. has authorized a buyback plan on November 28, 2023.
Chemclin Diagnostics Co., Ltd.
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.53 CNY | -1.05% | -4.44% | -30.21% |
05-03 | Chemclin Diagnostics Launches Homegrown Immunodetection Kits | MT |
04-29 | Chemclin Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.21% | 422M | |
-4.62% | 12.18B | |
+8.48% | 5.96B | |
+27.69% | 5.45B | |
-6.28% | 4.34B | |
-52.57% | 3.18B | |
+12.93% | 2.75B | |
+30.93% | 2.3B | |
-3.80% | 2.28B | |
-4.64% | 1.92B |
- Stock Market
- Equities
- 688468 Stock
- News Chemclin Diagnostics Co., Ltd.
- Chemclin Diagnostics Co., Ltd. authorizes a Buyback Plan.